Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The purpose of the study is to evaluate whether Oncoxin, a nutritional supplement, improves the clinical and ultrasonographic results in comparison with placebo during 24 weeks of treatment.
Epistemonikos ID: 492108b6bceea8dac2df27a5c62988bcb97f909c
First added on: May 05, 2024